Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged between 18 and 80 years old
- People who have been diagnosed with coronary heart disease during a hospital stay through a procedure that looks at the heart's arteries (coronary angiography), including heart attacks with a specific pattern on a heart tracing (STEMI), other types of acute heart conditions without that pattern (NST-ACS), or stable chest pain (stable angina)
- People whose kidney function has been clearly assessed, including those with chronic kidney disease defined as having reduced kidney filtering ability or elevated levels of a protein called albumin in the urine, lasting more than 3 months (confirm with trial site for exact measurements)
Who may not be able to join:
- People who are pregnant or breastfeeding
- People with severe heart valve disease or serious heart complications that require surgery
- People with severe mental illness or other reasons that would make it difficult to attend follow-up appointments
- People with serious blood disorders or advanced-stage cancer
- People who have had a kidney transplant or who are on long-term dialysis
- People with severe liver disease (a specific medical classification called Child-Pugh class C)
- People who received dialysis treatment for sudden kidney failure within the 12 weeks before joining the trial
- People with severe chronic lung disease requiring long-term breathing machine support or who are waiting for a lung transplant
- People whose life expectancy is less than one year
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Zheng Jingang, MD, China-Japan Friendship Hospital
Phone: +86 13882712184
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of cardiovascular adverse events; Incidence of Renal composite endpoint event
Can't join this trial?
Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.